Improving Maternal Nutrition in Matlab (IMNiM)

In-home, Intensive Nutrition Counseling to Improve Gestational Weight Gain in Rural Bangladesh: A Cluster-Randomized Controlled Trial

Background: Maternal undernutrition and inadequate gestational weight gain (GWG) are prevalent in rural communities of low- and middle-income countries (LMICs). In Matlab, Bangladesh, 54% of the women fail to gain adequate weight (>4 kg) in the third trimester. Risks associated with inadequate GWG include giving birth to a small-for-gestational age (SGA) infant, low birth weight (LBW) infant, preterm birth (PTB), etc. Few contemporary studies examined the efficacy of nutrition counseling on GWG improvement in LMICs.

Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.

Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.

Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.

Study Overview

• Status: Active, not recruiting
• Conditions: Gestational Weight Gain
• Intervention / Treatment: Behavioral: In-home, intensive nutrition counseling

• Study Type: Interventional
• Enrollment (Actual): 287
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Bangladesh
  • Chandpur, Bangladesh
    • International Centre for Diarrhoeal Disease Research, Bangladesh

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 39 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Pregnant women permanently residing in the icddr,b service area of Matlab fulfilling the following criteria:

Inclusion Criteria:

• aged 18-39 years
• in the first trimester of pregnancy (before 14 weeks of gestation)
• BMI 16-24.99 kg/m^2 measured on enrollment
• willing to participate in the study

Exclusion criteria

• multiple pregnancy (carrying two or more fetuses)
• threatened abortion, persistent pervaginal bleeding, or cervical incompetence
• history of three or more consecutive abortions
• history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
• chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
• taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
• known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
• scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
• inability to read or write Bengali
• belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
• having a plan to move or deliver outside the study area
• women practicing some form of vegetarianism
• women belonging to a household from which another woman is already enrolled in the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention; In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.	Behavioral: In-home, intensive nutrition counseling; Individualized sessions will be conducted by trained health workers following a standard document (counseling booklet); The messages to be provided through the counseling will be contextualized; Sessions will start from the early second trimester and repeat monthly until 36 weeks of gestation; Counseling sessions will be conducted at the participant's place; Sessions will involve influential family members such as the husband, mother-in-law, mother, and the household head along with the pregnant women; Women will receive personalized feedback on their dietary intake pattern (dietary diversity) and the rate of weight gain in each session; Sessions will be tailored according to each participant's need and progress
No Intervention: Control; Pregnant women in this arm will receive standard antenatal care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to IOM 2009 guidelines	Pregnancy trimesters are defined as follows: 1st trimester (0 weeks - 13+6 weeks), 2nd trimester (14 completed weeks - 27+6 weeks), and 3rd trimester (28 completed weeks - childbirth). Rate of weight gain between two time points (trimesters) will be calculated by subtracting the weight measured at the first time point from the weight measured at the second time point and dividing the derived value by the difference in weeks between the two time points.	Pre-delivery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
total gestational weight gain (kg)		pre-delivery
rate of weight gain during the 2nd and 3rd trimester (kg/week)		pre-delivery
proportion of women with inadequate total GWG according to IOM criteria		pre-delivery
proportion of women with inadequate total GWG according to local criteria		pre-delivery
proportion of women with inadequate third trimester weight gain according to local criteria		pre-delivery
proportion of preterm births	childbirth before 37 completed weeks	at delivery
maternal mid-upper arm circumference (MUAC) (mm)		baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
maternal weight (kg)		baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
maternal body mass index (BMI) (kg/m^2)	weight and height (at baseline) will be combined to report BMI	baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
infant weight (g)		at birth (delivery) and after 4 weeks
infant length (cm)		at birth (delivery) and after 4 weeks
infant head circumference (cm)		at birth (delivery) and after 4 weeks
proportion of low birth weight (< 2500 g) infants		at birth (delivery)
proportion of small for gestational age (<10th percentile) infants according to Intergrowth-21st standards		at birth (delivery)
proportion of women with pregnancy complications e.g. anemia, preeclampsia		at delivery
proportion of women with obstetric complications e.g. induction of labor, caesarean section		at delivery
newborn Apgar score		at birth (delivery)
proportion of infants developing morbidity		4 weeks after birth
proportion of infant mortality		4 weeks after birth
dietary diversity score according to the "Guidelines for Measuring Household and Individual Dietary Diversity"	score range: 0-9; higher scores indicate a better outcome	baseline, 36 weeks of gestation and 6 weeks post-partum
dietary diversity score according to the "Minimum Dietary Diversity for Women: A Guide to Measurement"	score range: 0-10; higher scores indicate a better outcome	baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with inadequate dietary diversity accroding to the "Minimum Dietary Diversity for Women: A Guide to Measurement"	score range: 0-10; <5 indicates inadequate dietary diversity	baseline, 36 weeks of gestation and 6 weeks post-partum
energy consumption (kcal)		baseline, 36 weeks of gestation and 6 weeks post-partum
protein consumption (g)		baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of depression as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales	DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.	baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of anxiety as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales	DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.	baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of stress as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales	DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.	baseline, 36 weeks of gestation and 6 weeks post-partum
healthcare seeking and services utilization e.g. number of prenatal visits		at delivery

Collaborators and Investigators

• Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
• Collaborators: Obstetrical and Gynaecological Society of Bangladesh (OGSB)
• Investigators: Principal Investigator: S. M. Tafsir Hasan, MBBS, MS, Nutrition and Clinical Services Division, icddr,b

Study record dates

Study Major Dates

• Study Start (Actual): January 15, 2020
• Primary Completion (Anticipated): September 30, 2021
• Study Completion (Anticipated): October 31, 2021

Study Registration Dates

• First Submitted: December 28, 2019
• First Submitted That Met QC Criteria: April 27, 2021
• First Posted (Actual): May 3, 2021

Study Record Updates

• Last Update Posted (Actual): May 3, 2021
• Last Update Submitted That Met QC Criteria: April 27, 2021
• Last Verified: April 1, 2021

More Information

Terms related to this study

• Keywords: gestational weight gain; birth weight; cluster randomized controlled trial; nutrition counseling
• Additional Relevant MeSH Terms: Body Weight; Body Weight Changes; Weight Gain; Gestational Weight Gain
• Other Study ID Numbers: PR-19109

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No